Pierre Beaurang - Net Worth and Insider Trading

Pierre Beaurang Net Worth

The estimated net worth of Pierre Beaurang is at least $3 Million dollars as of 2024-11-13. Pierre Beaurang is the Chief Business Officer of Nurix Therapeutics Inc and owns about 120,996 shares of Nurix Therapeutics Inc (NRIX) stock worth over $3 Million. Details can be seen in Pierre Beaurang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pierre Beaurang has not made any transactions after 2021-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Pierre Beaurang

To

Pierre Beaurang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pierre Beaurang owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .

Click here to see the complete history of Pierre Beaurang’s form 4 insider trades.

Insider Ownership Summary of Pierre Beaurang

Ticker Comapny Transaction Date Type of Owner
NRIX Nurix Therapeutics Inc 2021-08-10 Chief Business Officer

Pierre Beaurang Latest Holdings Summary

Pierre Beaurang currently owns a total of 1 stock. Pierre Beaurang owns 120,996 shares of Nurix Therapeutics Inc (NRIX) as of August 10, 2021, with a value of $3 Million.

Latest Holdings of Pierre Beaurang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NRIX Nurix Therapeutics Inc 2021-08-10 120,996 27.02 3,269,312

Holding Weightings of Pierre Beaurang


Pierre Beaurang Form 4 Trading Tracker

According to the SEC Form 4 filings, Pierre Beaurang has made a total of 7 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 7,500 shares on August 10, 2021, which brought Pierre Beaurang around $223,950.

Insider Trading History of Pierre Beaurang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pierre Beaurang Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pierre Beaurang Ownership Network

Ownership Network List of Pierre Beaurang

No Data

Ownership Network Relation of Pierre Beaurang

Insider Network Chart

Pierre Beaurang Owned Company Details

What does Nurix Therapeutics Inc do?

Who are the key executives at Nurix Therapeutics Inc?

Pierre Beaurang is the Chief Business Officer of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include General Counsel Christine Ring , Chief Financial Officer Houte Hans Van , and Chief Scientific Officer Gwenn Hansen .

Nurix Therapeutics Inc (NRIX) Insider Trades Summary

Over the past 18 months, Pierre Beaurang made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 67,327 shares made by Christine Ring , a net sale of 82,022 shares made by Houte Hans Van , and a net sale of 14,703 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 70,553 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 70,553 shares. During the past 18 months, 164,052 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 164,052 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nurix Therapeutics Inc Insider Transactions

No Available Data

Pierre Beaurang Mailing Address

Above is the net worth, insider trading, and ownership report for Pierre Beaurang. You might contact Pierre Beaurang via mailing address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco Ca 94158.